Duchemin Jeffrey
Chief Executive Officer at HBIO
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Apr 12, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- HBIOHARVARD BIOSCIENCE INCChief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale HBIOPlan not statedJun 12, 2017 2017
Sold 22,000 shares at $2.66 ($59k)
Duchemin Jeffrey, Chief Executive Officer
Sold 2.7% of holdings ($2.2M position)788,984 shares leftFirst sale on recordFiling
- 2 Form 4 sale HBIOPlan not statedMar 9, 2018 +270 days
Sold 87,022 shares at $4.53 ($394k)
Duchemin Jeffrey, Chief Executive Officer
Sold 11.9% of holdings ($3.3M position)641,854 shares leftFiling
- 3 Form 4 sale HBIOPlan not statedJul 11, 2018 +124 days
Sold 40,000 shares at $5.33 ($213k)
Duchemin Jeffrey, Chief Executive Officer
Sold 4.8% of holdings ($4.4M position)790,742 shares leftFiling
- 4 Form 4 sale HBIOUnusualAug 9, 2018 +29 days
Sold 150,000 shares at $6.18 ($927k)
Duchemin Jeffrey, Chief Executive Officer
Sold 15.9% of holdings ($5.8M position)790,742 shares left3.8x usual sizeFiling
- 5 Form 4 sale HBIOPlan not statedApr 12, 2019 +246 days
Sold 19,157 shares at $4.51 ($86k)
Duchemin Jeffrey, Chief Executive Officer
Sold 2.3% of holdings ($3.8M position)830,888 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2019 | Apr 12, 2019 | HBIO | Chief Executive Officer | Form 4 sale | 19,157 | $86k | 2.3% | Plan not stated | SEC |
| Aug 9, 2018 | Aug 9, 2018 | HBIO | Chief Executive Officer | Form 4 sale | 150,000 | $927k | 15.9% | Unusual | SEC |
| Jul 11, 2018 | Jul 11, 2018 | HBIO | Chief Executive Officer | Form 4 sale | 40,000 | $213k | 4.8% | Plan not stated | SEC |
| Mar 9, 2018 | Mar 12, 2018 | HBIO | Chief Executive Officer | Form 4 sale | 87,022 | $394k | 11.9% | Plan not stated | SEC |
| Jun 12, 2017 | Jun 13, 2017 | HBIO | Chief Executive Officer | Form 4 sale | 22,000 | $59k | 2.7% | Plan not stated | SEC |